Gastric Cancer

Clinical trial landscape

1820 registered studies reference this disease. The split below shows how many are ongoing versus completed per phase.

Phase	Total	Ongoing	Completed
Phase 2	487	129	186
Unknown	441	144	166
Not applicable	301	115	97
Phase 1	205	72	80
Phase 3	161	39	74
Phase 1/2	136	45	39
Phase 4	41	9	18
Phase 2/3	31	11	7
Early Phase 1	17	7	3
All phases	1820	571	670

Ongoing Completed Balance withdrawn, terminated, or status unreported.

12 Aug 26	ESMO GI 2026: AI Biomarkers and Clinical Value in Cancer Care	oncodaily.com ↗
08 Aug 26	New Studies Reveal Promising Cancer Targets and Treatment Strategies	medicalxpress.com ↗
25 Jul 26	BTK Resistance Mutation, China CAR-T Review, and BET Inhibitor Insights Mark Cancer Research Advances	scitechdaily.com ↗
21 Jul 26	BioNTech Posts $622.3M Loss in Q1 2026 as Oncology R&D Surges	pharmexec.com ↗
08 Jul 26	Ferroptosis and Cuproptosis Emerge as Key Cancer Therapy Targets in New Studies	dovepress.com ↗
24 Jun 26	CT-Based Biomarker Improves Gastric Cancer Prognosis; PET Imaging Market Grows; Neuroendocrine Tumor Research Advances	cancernetwork.com ↗
04 Jun 26	Dual Immunotherapy Avoids Surgery in 70.6% of MSI-H Gastric Cancer Patients	medscape.com ↗
02 Jun 26	Multiple Oncology Trials Report Positive Results at ASCO 2026 and in Journals	ascopost.com ↗
31 May 26	BioNTech, BioLineRx Unveil Clinical Data at ASCO 2026	bioworld.com ↗
13 May 26	ABL111 gains FDA accelerated approval pathway as phase 2 gastric cancer trial begins	targetedonc.com ↗

Headlines link to the original publisher. Sources limited to a reviewed list of journals, regulators, and medical press.